Evaluation of human papillomavirus elimination from cervix uteri by infrared laser exposure.
Elimination of types 16 and 18 human papilloma virus from the surface of cervix uteri for secondary prevention of cervical cancer was evaluated. The method is protected by patent of invention of the Russian Federation. Infrared laser therapy of cervix uteri was carried out in patients with precancer diseases of cervix uteri at Department of Gynecology of Municipal Clinical Hospital No. 52 (Moscow). Papillomavirus infection was eliminated using a Russian diode laser (lambda=1.06 μ, radiation power 10 W) with a collimating headpiece using carbon die at a distance of 10-12 cm from the exposed surface. The treatment resulted in a high percentage of elimination of types 16 and 18 oncogenic virus 4-6 weeks and during delayed periods after exposure.
Moscow Municipal Clinical Hospital No. 52, Russian Academy of Medical Sciences, Moscow, Russia.
V P
VP
Dymkovets
V V
VV
Ezhov
A A
AA
Manykin
S V
SV
Belov
Yu K
YK
Danileiko
V V
VV
Osiko
V A
VA
Salyuk
D000328:Adult; D002584:Cervix Uteri / Q000601:surgery* / Q000821:virology*; D005260:Female; D052162:Human papillomavirus 16 / Q000472:pathogenicity; D052161:Human papillomavirus 18 / Q000472:pathogenicity; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D008875:Middle Aged; D027383:Papillomaviridae / Q000472:pathogenicity*; D011230:Precancerous Conditions / Q000601:surgery* / Q000821:virology*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology*